Inuit and Cold Exposure
ICE
Metabolic Effects of Short-term Cold Exposure Among Greenlanders and Non-Greenlanders
1 other identifier
observational
25
1 country
1
Brief Summary
Brown adipose tissue (BAT) produces heat through non-shivering thermogenesis. It is activated by cold exposure, and when activated it utilizes fatty acids and glucose in order to produce heat. The tissue is especially present in newborns, who not yet have gained a layer of insulating fat to protect from heat loss, and not yet have gained much muscle to produce heat through shivering thermogenesis. It was long thought that BAT mass hereafter would retract. Modern imaging tools have proved that BAT is persistent and active in some adults. The presence and activity of BAT is negatively correlated with obesity and obesity-related metabolic disorders. The tissue retracts with advancing age and increasing BMI, and it is sensitive to environmental factors, such as diet, weather and climate. The key to activating BAT in subjects that have lost it remains elusive. BAT is activated to produce heat when exposed to cold. Populations that are most cold exposed include people living in the Arctic. It is known that people of Arctic origin such as indigenous Inuit and indigenous Siberians have genetically adapted to and are acclimatized to the cold through several genetic changes, and possibly by upregulating BAT depots and activity. The investigators aim to dig deeper into the activation mechanisms in BAT, by investigating BAT mass and activity in Greenlanders and non-Greenlanders by use of stage-of-the-art modern techniques.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 4, 2023
CompletedFirst Posted
Study publicly available on registry
June 1, 2023
CompletedStudy Start
First participant enrolled
September 18, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedAugust 22, 2023
August 1, 2023
1.2 years
May 4, 2023
August 21, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
BAT detection
BAT mass in the cervical-upper thoracic, abdominal, and paravertebral regions at room temperature and following short-term cold exposure. BAT mass on PET/CT scans will be quantified by the degree of glucose uptake: Maximum standard unit value (SUVmax)
Through study completion, analysis for an average of 1 year
Secondary Outcomes (5)
Temperature of the core and at the skin on multiple sites
Through study completion, analysis for an average of 1 year
Changes in thyroid function
Through study completion, analysis for an average of 1 year
Changes in metabolites
Through study completion, analysis for an average of 1 year
Insulin sensitivity
Through study completion, analysis for an average of 1 year
Adipose tissue composition
Through study completion, analysis for an average of 1 year
Study Arms (2)
Greenlanders
Subjects born in Greenland with parents born in Greenland
non-Greenlanders
Subjects not born in Greenland with parents not born in Greenland
Interventions
Eligibility Criteria
Healthy, lean, young Greenlanders and non-Greenlanders living in Denmark
You may qualify if:
- Ability to give informed consent
- Ability to follow written and verbal instructions
You may not qualify if:
- Pregnancy and breastfeeding
- Alpha- or beta-adrenergic affecting medication.
- Thyroid dysfunction
- Liver or kidney disease
- Treatment for diabetes
- MODY and TBC1D4
- Treatment of obesity
- Cardiovascular disease
- Cancer within 3 years
- Mb Renaud
- Hospitalisation for psychiatric disease
- Antipsychotic medication
- Drug abuse within 1-year
- Alcohol abuse
- Plasma glucose \> 11 mM
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Stig Andersenlead
- University of Copenhagencollaborator
- Greenland Universitycollaborator
Study Sites (1)
Aalborg University Hospital
Aalborg, 9000, Denmark
Related Publications (1)
Motzfeldt Jensen M, Almasi CE, Kjaergaard B, Rasmussen BS, Andersen MK, Schubert M, Hansen T, Ellervik C, Scheele C, Jorgensen ME, Andersen S. Brown Adipose Tissue and Metabolic Markers Differ Between Greenlanders and Danes with Cold-Activation. J Clin Endocrinol Metab. 2025 Nov 17:dgaf615. doi: 10.1210/clinem/dgaf615. Online ahead of print.
PMID: 41243523DERIVED
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor, Department Head
Study Record Dates
First Submitted
May 4, 2023
First Posted
June 1, 2023
Study Start
September 18, 2023
Primary Completion
December 1, 2024
Study Completion
December 1, 2025
Last Updated
August 22, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share
Restrictions apply due to limited number of participants